Read the latest news about research and scientific resultats on Alzheimer's disease at the Barcelonaβeta Brain Research Center (BBRC).
These findings reinforce the robustness of current CSF tools for early detection while encouraging sex-aware interpretation when tracking disease biology over time
The international study shows that this biomarker allows detection of the presence of amyloid beta deposits, a key pathology in the development of the disease, in individuals without cognitive impairment
A clinical trial conducted jointly by the Research Institute of Hospital del Mar and the Barcelonaβeta Brain Research Center, concludes that combining a healthy lifestyle program with epigallocatechin gallate (EGCG), a natural compound found in green tea, could offer sustained cognitive benefits in people at high risk of developing Alzheimer’s dise
This research achieved a more precise measurement of sleep quality thanks to the combined use of actigraphy, brain MRI scans, and biomarker analysis.
The international consortium has analyzed almost 40,000 biological samples to identify biomarkers in Alzheimer’s, Parkinson’s, ALS, and other neurodegenerative diseases.
This study suggests that certain stressful life events can impact brain health differently depending on gender and educational level
This fully automated blood test could become a scalable, minimally invasive tool to detect and monitor Alzheimer’s-related changes long before symptoms appear.
The study, published in the journal Alzheimer’s & Dementia, involved 337 people from the ALFA longitudinal cohort of the Barcelonaβeta Brain Research Center (BBRC), with the support of the “la Caixa” Foundation.
A study involving more than 1,700 people from five hospitals in Barcelona, Sweden and Italy has validated the usefulness of a biomarker in blood to detect Alzheimer's disease in the clinical setting.